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Abstract
We report microsecond timescale molecular dynamics simulation of the complex formed
between Pt(II)-phenanthroline and the 16 N-terminal residues of the Aβ peptide that is impli-
cated in the onset of Alzheimer’s disease, along with equivalent simulations of the metal-
free peptide. Simulations from a variety of starting points reach equilibrium within 100 ns, as
judged by root mean square deviation and radius of gyration. Platinum-bound peptides devi-
ate rather more from starting points, and adopt structures with larger radius of gyration, than
their metal-free counterparts. Residues bound directly to Pt show smaller fluctuation, but
others actually move more in the Pt-bound peptide. Hydrogen bonding within the peptide is
disrupted by binding of Pt, whereas the presence of salt-bridges are enhanced.
Introduction
Alzheimer’s disease (AD) is one of the greatest healthcare challenges facing modern society.[1]
Its aetiology is complex, but the importance of amyloid-β (Aβ) peptides and their aggregation
is well established.[2][3][4][5] AD is associated with formation of fibrils and plaques (dense,
insoluble deposits of protein and cellular material outside and around neurons) in brain tissue
that impair proper functioning of neurons. Plaques are formed by aggregation of Aβ that are
soluble in isolation, but insoluble when bound to one another. The presence of metals, notably
copper, zinc and iron, is a vital part of the aggregation and subsequent toxicity of Aβ: increased
levels of Cu and Zn are found in plaque regions of diseased brain, [6][7] and those plaques
which do not contain metal ions have been found to be non-toxic.[8] Moreover, platinum
complexes inhibit aggregation,[9][10][11] opening new avenues for treatment and diagnosis.
In these, ligand choice proves to be vital, with large planar aromatic groups acting to stabilise
complexes between Pt and Aβ.[9][12][13]
Structural details for naturally occurring metals such as Cu and Zn have been elucidated
through a wide range of experimental [14][15] and simulation techniques,[16][17][18][19] but
the equivalent for Pt is scarcer. Ma et al used HPLC, ESI-MS and NMR spectroscopy to exam-
ine the binding of PtII-phenanthroline to Aβ, suggesting that binding to His6 and His14 pre-
dominates and that π-stacking to aromatic residues Phe4, Tyr10 and His13 may also play a
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role.[20][21] In addition, Streltsov et al used a combination of EXAFS and DFT to probe local
binding environment at Pt and derive structural models for the interaction of platinum com-
plexes with Aβ16 and Aβ42.[22] Recently, we showed that ligand field molecular mechanics
(LFMM) [23][24][25] is an appropriate method to probe the binding of Pt to fragments of Aβ,
characterising the effect of Pt complexes on limiting conformational freedom of the peptide
[26] and the role of ligand variation in complexes formed and 3D conformation adopted. [27]
In this work, we extend this approach to examine the dynamical behaviour of a typical Pt-Aβ
adduct using molecular dynamics simulations and LFMM description of metal coordination
coupled with conventional molecular mechanics (MM) for the peptide.
Computational details
Molecular Dynamics simulations were carried out using a modified version of DL_POLY 2.0
[28] that incorporates LFMM energies and forces.[29] Pt(Aβ) complexes were described using
a combination of LFMM for Pt(II) [29][30] and AMBER94 [31] parameters for all other
atoms. The Aβ1–16 peptide was built in extended conformation in MOE,[32] and protonation
states at pH 7.4 assigned using the Protonate3D module of this package. Pt-phenanthroline
complexes were bound to the peptide via His6-Nε and His14-Nε, as identified in our previous
work.[26][27] Initial peptide conformations were selected from a LowMode Molecular
Dynamics [33] simulation in MOE as reported previously. DL_POLY input files were gener-
ated using DL_FIELD [34] and the DommiMOE [24] extension to MOE.
For all simulations of the free Aβ peptide, AMBER94 partial charges assigned by MOE were
used. For Pt(phen)-Aβ simulations, Merz-Kollman charges were calculated for model Pt
(phen)-imidazole systems from HF/6-31G(d)/SDD electrostatic potential in Gaussian09,[35]
with PtII given a van der Waals radius of 2.0 Å (see ESI). The remaining peptide atoms were
assigned AMBER94 charges as calculated by MOE.
Simulations were performed on isolated systems, with reaction field solvation in dielectric
constant 78.4. Simulations were performed in the NVT ensemble, where temperature was con-
trolled at 310 K using the Nose´-Hoover thermostat [36][37] with relaxation constant 0.5 ps.
Equations of motions were integrated using a Verlet Leapfrog algorithm, with a timestep of 1
fs. The SHAKE algorithm [38] with tolerance 10−8 Å was used to constrain bonds containing
hydrogen. The vdW forces were calculated with a cutoff of 1 nm, while 2.1 nm was used as a
cutoff for electrostatics. In each molecular dynamics trajectory, atomic positions and velocities
were recorded every 500 fs and used for subsequent analysis.
Resulting MD trajectories were analysed using VMD, [39] with root mean square deviation
(RMSD), radius of gyration, peptide secondary structure, hydrogen bonds, salt bridges, solvent
accessible surface area and RMSF data recorded. The STRIDE algorithm [40], as implemented
in VMD, was used to characterise each residue as either Turn, β-sheet, β-bridge, α-helix, 310-
helix, π-helix or Coil- type structure.
Results and discussion
Five simulations (labelled A-E) of the free Aβ16 fragment were carried out, each for 200 ns,
along with five simulations (labelled F-J) for the Pt(Aβ16) system. Table 1 illustrates that all
initial conformations are significantly different from one another, ensuring efficient sampling
of the molecular phase space during simulations. Fig 1 shows an overlap of starting points of
simulations F–J, showing the variation of backbone and sidechain conformations adopted.
Equilibration of all ten simulations was monitored initially via the RMSD relative to starting
points, as shown in Fig 2. Following recent work on Aβ40 [41] and Aβ42 [18], we consider
that these simulations are ‘pseudo-equilibrated’ as RMSD fluctuates around a central point by
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approximately 1 Å after a period of time taken as 80, 40, 10, 20 and 10 ns for A-E, 50, 25, 30, 25
and 25 ns for F-J, respectively. Simulation data beyond these points were used for further
analysis.
Table 2 summarises RMSD relative to the initial configuration for all ten sets of production
MD runs. Free peptide values vary between 2.7 and 3.5 Å, with standard deviations in the
range 0.1 to 0.2 Å, indicating relatively small movement from starting point and hence at least
pseudo-equilibration of the individual simulations. Platinated peptides exhibit larger changes,
equilibrating to between 3.0 and 6.3 Å, with maximum values also rather larger than those
seen for the free peptide but standard deviations of similar magnitude, suggesting that these
structures fluctuate to a similar degree. Moreover, RMSD values vary rather more between dif-
ferent simulations than within each one (A-E: mean = 3.03 Å, sd = 0.30 Å; F-J: mean = 4.36 Å,
sd = 1.22 Å). This highlights the importance of using multiple starting points, since any one
simulation reaches pseudo-equilibration relatively quickly and does not visit the entire config-
urational phase space available to the peptide.
Fig 3 shows radius of gyration (Rg) data for ten simulations, with post-equilibration data
summarised in Table 3. These show that the free Aβ16 fragment adopts a relatively compact
structure, with Rg values typically less than 7 Å: for comparison, Aβ16 in an extended confor-
mation has Rg of 16.99 Å, and in α-helical structure, 9.16 Å. Possible intra-molecular interac-
tions that might give rise to these compact conformations are considered below. The standard
Table 1. RMSD between starting points of free and platinated peptides.
RMSD (Å) A B C D E F G H I J
A - 2.140 4.420 6.459 8.213 F - 7.605 6.334 7.485 6.323
B - - 4.310 6.362 8.259 G - - 6.400 3.301 5.949
C - - - 5.488 7.261 H - - - 5.774 5.807
D - - - - 5.763 I - - - - 5.797
E - - - - - J - - - - -
https://doi.org/10.1371/journal.pone.0193668.t001
Fig 1. Starting points of simulations F–J. Pt(phen) aligned, backbone shown as tube, sidechains as wireframe and Pt
(phen)(imid)2 in black.
https://doi.org/10.1371/journal.pone.0193668.g001
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deviation within each simulation is also small, indicating that there is little change in the com-
pactness of the peptide structure during any one simulation. In general, different simulations
display a similar range of Rg values (A-E: mean = 6.74 Å, sd = 0.15 Å; F-J: mean = 7.83 Å,
sd = 0.50 Å). This suggests that while the peptide as a whole remains compact, flexible peptide
side-chains may be responsible for the similar degree of variation observed. However, simula-
tion C has slightly larger average Rg value than the others: interestingly, C also displayed the
greatest average RMSD value of the Aβ16 systems studied, suggesting that this simulation
occupies a somewhat different configuration than the others.
Pt(Aβ16) simulations display significantly larger mean Rg values than their free peptide
counterparts, indicating that coordination of the large, sterically demanding Pt-phen forces
the structure to adopt less compact conformations. Standard deviation is consistent across
these simulations, though slightly larger than for the free peptide systems. Pt(Aβ16) simula-
tions are centred around 3 distinct Rg values, ca. 7.45 Å, 7.78 Å and 8.66 Å. F displays the
Fig 2. RMSD vs time for simulations A-J.
https://doi.org/10.1371/journal.pone.0193668.g002
Table 2. Mean, standard deviation, maximum and minimum RMSD relative to starting point for production MD
data (Å).
Mean SD Min. Max.
A 2.946 0.084 2.535 3.514
B 3.043 0.162 2.299 3.774
C 3.503 0.140 2.671 4.182
D 2.969 0.088 2.549 3.485
E 2.686 0.149 2.090 3.449
F 6.292 0.101 5.68 6.777
G 4.224 0.192 3.251 4.887
H 2.983 0.135 2.413 3.471
I 3.794 0.166 3.013 4.382
J 4.501 0.176 3.628 5.092
https://doi.org/10.1371/journal.pone.0193668.t002
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largest Rg of all Pt(Aβ16) simulations (8.66 ± 0.2 Å), significantly larger than all other confor-
mations examined. Interestingly, this conformation displays a high prevalence of stabilising π-
π interactions (vide infra), which may cause the peptide backbone to extend and re-organise in
order to accommodate these stacking arrangements. Simulations G and I display identical Rg:
comparison of the final snapshot of the each trajectory shows that the structures are near-iden-
tical (RMSD = 0.11 Å compared with 3.30 Å at starting points), showing that the simulations
converged to a common structure within the equilibration period.
Root mean square fluctation (RMSF) of each residue was measured for production MD, as
shown in Fig 4 (data from individual trajectories are shown in ESI). For the free peptide, large
RMSF values are observed for Phe4, His6, Tyr10 and Val12, and small values for Asp1, Glu3,
Arg5, and Glu11. Coordination of Pt(phen) at histidines 6 and 14 unsurprisingly reduces their
RMSF, with Phe4 also moving less than in the metal-free case, whereas values for Tyr10, Val12
and Lys15 are on average larger after metallation. These data therefore suggest that coordina-
tion of Pt(phen) affects the peptide in more subtle ways than might first be thought, in
Fig 3. Radius of gyration of simulations A–J.
https://doi.org/10.1371/journal.pone.0193668.g003
Table 3. Mean, standard deviation, maximum and minimum radius of gyration for production MD data (Å).
Mean SD Min Max
A 6.695 0.060 6.456 7.084
B 6.627 0.095 6.324 7.178
C 6.998 0.057 6.610 7.291
D 6.706 0.051 6.483 7.060
E 6.675 0.058 6.450 7.043
F 8.659 0.196 7.932 9.173
G 7.786 0.125 7.252 8.165
H 7.417 0.126 7.085 7.812
I 7.786 0.125 7.252 8.156
J 7.481 0.095 7.121 7.831
https://doi.org/10.1371/journal.pone.0193668.t003
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particular promoting more flexibility in resiudes lying between coordination sites. However,
differences between free and Pt(phen) trajectories are of similar magnitude to those between
repeat simulations. RMSF for Tyr10, for instance, is relatively constant at 0.53 ± 0.09 Å over 5
Fig 4. Average RMSF for Aβ16 and Pt(Aβ16), and the difference between average values.
https://doi.org/10.1371/journal.pone.0193668.g004
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simulations of the free peptide, but varies rather more (0.67 ± 0.31 Å, max = 0.95 Å, min =
0.29 Å) for the equivalent Pt(phen) trajectories. Only three residues (His6, His14 and Gln15)
exhibit differences in RMSF that exceed the sum of standard deviations: full details can be
found in Supporting Information.
In addition, the effect of PtII(phenanthroline) coordination on secondary structure was
determined. Percentages of each type of structure over all simulations is shown in Fig 5, with
numerical values reported in Supporting Information. As expected for an intrinsically disor-
dered peptide, most residues in the free peptide adopt coil or turn conformations. Interest-
ingly, there is a low propensity (4% of total simulation time) for residues Tyr10-Glu11-Val12
to form a 3 residue 3,10 helix, while residues Gly9 and Gln15 infrequently (4% of simulation)
adopt β-bridge structures. The prevalence of turn and coil structures in these simulations is in
good general agreement with most data for Aβ, though the propensity of residues to adopt
turn structures is high. Other authors have noted that STRIDE has a greater tendency to assign
turn structure than other secondary structure programs [42], but observed that most residues
in Aβ exist as turn structure with approximately 30–80\% probability. In addition, previous
simulations of Aβ42 [42] displayed 3,10-helical structure for residues Tyr10-Val12 of approxi-
mately 3–5%, in agreement with our data.
Fig 5. Percentage secondary structure of Aβ16 (top) and Pt(Aβ16) (bottom).
https://doi.org/10.1371/journal.pone.0193668.g005
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In the Pt(Aβ16) simulations, secondary structure is again predominantly assigned as either
turn or coil, but the percentages of each secondary structure element differs from the free pep-
tide. This indicates that coordination of Pt(phen) does not drastically change secondary struc-
ture, although Pt coordination shifts the 3,10-helix towards the C-terminus and increases its
incidence to 15% of total simulation time. Strikingly, residues involved in metal binding (His6,
His14) show an increase in defined secondary structure (turn and helix) in the Pt(Aβ16) simu-
lations, from approximately 50% in Aβ16 to 60–80% in the platinated system.
Hydrogen bond networks within free and platinated Aβ16 were also monitored (Table 4).
In both cases there is a large variation across trajectories, with as few as zero and as many as 17
(free) or 13 (platinated) present in production data. In general, the Pt(Aβ16) systems show
fewer hydrogen bonds than the free Aβ16 simulations, suggesting that the Pt(phenanthroline)
system may interfere with the natural hydrogen bonding patterns of Aβ16. However, this dif-
ference is not significant, given the large standard deviations (~1.9–2.0) on the mean number
of hydrogen bonds.
Intramolecular salt bridges, known to be important in the formation of fibrils,[43],[44]
were monitored during the course of the simulations. As the Aβ16 peptide fragment has two
positively charged and four negatively charged residues, there are a total of eight possible salt
bridge interactions. Each was monitored in VMD, defined as contact of less than 3.2 Å
between O/N atoms in charged residues. Resulting data are summarised in Fig 6 and Table 5.
In the free Aβ16 peptide, Arg5 predominantly interacts with Asp7 (86% of frames) but also
forms interactions with Glu11 (56%) and less frequently with Glu3 and Asp1. Lys16 forms salt
bridges most frequently with Asp1 (56%), and also interacts with Glu3 and Glu11 (20–30%).
In all trajectories, Lys16 never forms a salt bridge with Asp7. Binding of Pt(phen) induces clear
changes in salt bridge structure: Arg5 still interacts with Asp7 but with reduced frequency
(61%), and instead primarily interacts with Glu3 and Asp1 (ca. 80%), while no Arg5-Glu11
interactions are present. Lys16 forms a near-constant salt bridge with Glu11 (99%), as well as
frequent interactions with Asp7 (62%) and Asp1 (40%). In contrast to the free peptide, Lys16
does not form a salt bridge at all with Glu3 in the Pt(Aβ16) simulations. Overall, Pt coordina-
tion causes Arg5 to switch from bridges with Asp7 and Glu11 to Glu3 and Asp1, while Lys16
salt bridges are formed with Glu11 and Asp7 instead of Asp1. It is notable that the combined
percentage of observed salt bridge interactions exceeds 100%, indicating that residues are close
enough to their charged partners to simultaneously form multiple salt bridge interactions.
π-π stacking interactions between ligand and aromatic side chains are thought to be impor-
tant in targeting coordination to the N-terminus of Aβ, as well as stabilising adducts. Close
contacts between phen and side chains of Phe4, Tyr10 and His13 (defined as distance between
Table 4. Mean, standard deviation, maximum and minimum number of hydrogen bonds in trajectories A–J.
Mean SD Min Max
(A) 6.43 1.99 0 16
(B) 5.61 1.86 0 14
(C) 7.05 1.86 0 17
(D) 7.11 2.06 0 17
(E) 5.78 1.81 0 15
(F) 5.70 1.66 0 13
(G) 5.15 1.74 0 13
(H) 3.86 1.64 0 12
(I) 5.15 1.75 0 12
(J) 5.95 1.78 0 13
https://doi.org/10.1371/journal.pone.0193668.t004
Molecular dynamics simulation of Pt-amyloid binding
PLOS ONE | https://doi.org/10.1371/journal.pone.0193668 March 6, 2018 8 / 15
Molecular dynamics simulation of Pt-amyloid binding
PLOS ONE | https://doi.org/10.1371/journal.pone.0193668 March 6, 2018 9 / 15
Cγ and central C in phen) were monitored over simulations F–J. Distribution of these contacts
are shown in Fig 7, showing that Phe4 in particular forms frequent π-π interactions with the
ligand, with a high distribution of contacts < 5 Å. Tyr10 forms almost no π-π interactions with
the phenanthroline ligand, with only a few frames at distances of approximately 5–6 Å, while
His13 shows moderate distribution of states where the π-π inter-plane distance is less than 5
Å, sufficient for weak π-π interaction. Of particular interest is simulation F, where both Phe4
and His13 simultaneously form π-π stacking arrangements with the ligand for the final 150 ns
of the simulation, with one residue above and below the ligand plane, as shown in Fig 8. These
findings are in agreement with the findings of Ma et al [20][21], who reported stacking interac-
tions with side chains of aromatic N-terminal residues, although the dynamical nature of our
simulations reflect the highly flexible, intrinsically disordered nature of the Aβ peptide.
Conclusions
Molecular dynamics, using LFMM description of metal coordination coupled with AMBER
description of peptide, elaborates details of the structure and properties of the complex formed
between Pt-phenanthroline and the metal binding N-terminal fragment of amyloid-β peptide.
Using five distinct starting structures, along with analogous simulations of metal-free peptide,
we find that simulations reach equilibration within a few tens of nano-seconds. Equilibrated
data collected over more than 800 ns for metal-free and metallated peptides allow detailed
comparison of size, secondary structure, and formation of hydrogen bonding and salt bridges.
Small changes in overall size and are observed on Pt binding, but rather larger differences
in the mobility of individual residues, measured by root mean square fluctuation, occur.
Changes in secondary structure, hydrogen bonding and salt-bridges on complexation of Pt are
also observed: in general, His6 and His14 that are bound to Pt are less mobile and more struc-
tured than their Pt-free counterparts. Residues between these are slightly more mobile when
bound, and exhibit slightly greater propensity to adopt turn and 3–10 helical structures.
Hydrogen bonding is reduced by complexation, but salt bridges are more likely to form in the
presence of Pt, while close contacts between phenanthrene ligand and aromatic residues Phe4,
Tyr10 and His13 are present in at least some of the trajectories, with one structural motif of a
sandwich of phenanthrene between Phe4 and His13 observed in a significant proportion of
simulation time.
These studies represent first application of ligand field molecular dynamics (LFMD) to
address the effect of platinum coordination on amyloid-β structure and flexibility. Previous
work from our group concentrated on validating the LFMM method against DFT and the
small amount of experimental data available, and on use of conformational searching to exam-
ine the effect of variation in ligand structure. Here, we show for the first time that it is possible
to quantify the effect of Pt on the dynamical landscape of Aβ configurations adopted, showing
Fig 6. Percentage of frames containing specified salt bridges, averaged over trajectories A–E (top) and F–J
(bottom).
https://doi.org/10.1371/journal.pone.0193668.g006
Table 5. Percentage of frames containing specified salt bridges, averaged over all trajectories A–E and F–J.
Aβ16 Asp1 Glu3 Asp7 Glu11
Arg5 20.99 25.93 85.64 55.88
Lys16 55.90 21.39 0.00 28.57
Pt(Aβ16) Asp1 Glu3 Asp7 Glu11
Arg5 77.62 79.71 61.26 0.00
Lys16 39.57 0.00 61.91 99.44
https://doi.org/10.1371/journal.pone.0193668.t005
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that pseudo-equilibration of simulations is possible with relatively modest computational
resources. In summary, microsecond timescale molecular dynamics quantifies the subtle but
definite changes induced by coordination of Pt(phen) to the N-terminal portion of the amy-
loid-β peptide. This fragment is widely used as a model for the full, biologically relevant pep-
tides Aβ40 and Aβ42 and their interaction with metal ions: we intend to report analogous data
for these peptides in due course.
Fig 7. Distribution of phen contacts with (A) Phe4, (B) Tyr10 and (C) His13 (Å).
https://doi.org/10.1371/journal.pone.0193668.g007
Molecular dynamics simulation of Pt-amyloid binding
PLOS ONE | https://doi.org/10.1371/journal.pone.0193668 March 6, 2018 11 / 15
Supporting information
S1 Fig. Numbering of Pt(phen) region.
(TIF)
S2 Fig. Starting conformations of free Aβ16 for simulations. Top row: A, B and C. Bottom
row: D, E and F.
(TIF)
S3 Fig. Superposition of starting conformations of free Aβ16.
(TIF)
S4 Fig. Overlay of final snapshots of simulations G (grey) and I (yellow).
(TIF)
S5 Fig. RMSF for Aβ16 simulations. A-E (top) and Pt(Aβ16) simulations F-J (bottom).
(TIF)
S1 Table. Merz-Kollman partial charges for Pt(phen)(imid)2.
(PDF)
S2 Table. RMSF details from individual simulations (Å).
(PDF)
S3 Table. Percentage of secondary structures for simulations A–J.
(PDF)
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